Similar incidence of graft glomerulonephritis in recipients with definitively diagnosed glomerulonephritis and those with unknown etiology: a retrospective observational study

References

• Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):1–10. doi: 10.1111/j.1600-6143.2011.03686.x.
   PubMed Web of Science ®Google Scholar
• El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9(3):527–535. doi: 10.1111/j.1600-6143.2008.02519.x.
   PubMed Web of Science ®Google Scholar
• Chailimpamontree W, Dmitrienko S, Li G, et al. Probability, predictors, and prognosis of posttransplantation glomerulonephritis. J Am Soc Nephrol. 2009;20(4):843–851. doi: 10.1681/ASN.2008050454.
   PubMed Web of Science ®Google Scholar
• Sellarés J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12(2):388–399. doi: 10.1111/j.1600-6143.2011.03840.x.
   PubMed Web of Science ®Google Scholar
• Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry (RADR). Transplantation. 1999;68(5):635–641. doi: 10.1097/00007890-199909150-00007.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy MM, Liu S, Montez-Rath ME, et al. Kidney transplantation outcomes across GN subtypes in the United States. J Am Soc Nephrol. 2017;28(2):632–644. doi: 10.1681/ASN.2016020126.
   PubMed Web of Science ®Google Scholar
• Park H, Park WY, Kang SS, et al. Clinical outcomes of kidney transplantation in patients with biopsy-Proven glomerulonephritis. Transplant Proc. 2018;50(4):1009–1012. doi: 10.1016/j.transproceed.2018.02.039.
   PubMed Web of Science ®Google Scholar
• Dabade TS, Grande JP, Norby SM, et al. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant. 2008;8(6):1318–1322. doi: 10.1111/j.1600-6143.2008.02237.x.
   PubMed Web of Science ®Google Scholar
• Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant. 2006;6(9):2006–2012. doi: 10.1111/j.1600-6143.2006.01436.x.
   PubMed Web of Science ®Google Scholar
• Huang Y, Farkash E. Protocol biopsies: utility and limitations. Adv Chronic Kidney Dis. 2016;23(5):326–331. doi: 10.1053/j.ackd.2016.09.002.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299–311. doi: 10.1038/ki.2009.377.
   PubMed Web of Science ®Google Scholar
• Bia M, Adey DB, Bloom RD, et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Kidney Dis. 2010;56(2):189–218. doi: 10.1053/j.ajkd.2010.04.010.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Andany MA, Danielson B. A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure. Am J Kidney Dis. 2002;39(4):762–768. doi: 10.1053/ajkd.2002.31996.
   PubMed Web of Science ®Google Scholar
• Halimi JM. Low-grade proteinuria and microalbuminuria in renal transplantation. Transplantation. 2013;96(2):121–130. doi: 10.1097/TP.0b013e31828719fb.
   PubMed Web of Science ®Google Scholar
• Parajuli S, Swanson KJ, Alstott J, et al. Transplant kidney biopsy for proteinuria with stable creatinine: findings and outcomes. Clin Transplant. 2021;35(10):e14436.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim H, Cho HS, et al. Outcomes of kidney allograft in recipients with kidney disease of unknown etiology. Clin Transplant. 2013;27(6):866–874. doi: 10.1111/ctr.12247.
   PubMed Web of Science ®Google Scholar
• Lim WH, Wong G, McDonald SP, et al. Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause. Sci Rep. 2018;8(1):9021. doi: 10.1038/s41598-018-27151-4.
   PubMedGoogle Scholar
• Foroncewicz B, Mucha K, Florczak M, et al. Long-term outcome of renal transplantation: a 10-year follow-up of 765 recipients. Pol Arch Intern Med. 2019;129(7–8):476–483.
   PubMedGoogle Scholar
• Szymańska A, Mucha K, Kosieradzki M, et al. Organization of post-transplant care and the 5-year outcomes of kidney transplantation. Int J Environ Res Public Health. 2022;19(4):2010. doi: 10.3390/ijerph19042010.
   PubMed Web of Science ®Google Scholar
• Zuo L, Wang M. Chinese association of blood purification management of chinese hospital A. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol. 2010;74(1):S20–S22.
   PubMedGoogle Scholar
• Xu X, Ning Y, Shang W, et al. Analysis of 4931 renal biopsy data in Central China from 1994 to 2014. Ren Fail. 2016;38(7):1021–1030. doi: 10.1080/0886022X.2016.1183443.
   PubMed Web of Science ®Google Scholar
• Hou JH, Zhu HX, Zhou ML, et al. Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-Proven cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10–19. doi: 10.1159/000484717.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Cattran DC. Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation. Kidney Int. 2017;91(2):304–314. doi: 10.1016/j.kint.2016.08.030.
   PubMed Web of Science ®Google Scholar
• Andresdottir MB, Hoitsma AJ, Assmann KJ, et al. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol. 2001;56(4):279–288.
   PubMed Web of Science ®Google Scholar
• Kennard AL, Jiang SH, Walters GD. Increased glomerulonephritis recurrence after living related donation. BMC Nephrol. 2017;18(1):25. doi: 10.1186/s12882-016-0435-z.
   PubMedGoogle Scholar
• Wang AY, Lai FM, Yu AW, et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis. 2001;38(3):588–596. doi: 10.1053/ajkd.2001.26885.
   PubMed Web of Science ®Google Scholar
• Han SS, Huh W, Park SK, et al. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy. Transpl Int. 2010;23(2):169–175. doi: 10.1111/j.1432-2277.2009.00966.x.
   PubMed Web of Science ®Google Scholar
• Schena FP, Cerullo G, Rossini M, et al. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol. 2002;13(2):453–460. doi: 10.1681/ASN.V132453.
   PubMed Web of Science ®Google Scholar
• Göbel U, Eichhorn J, Kettritz R, et al. Disease activity and autoantibodies to endothelial cells in patients with wegener’s granulomatosis. Am J Kidney Dis. 1996;28(2):186–194. doi: 10.1016/s0272-6386(96)90300-5.
   PubMed Web of Science ®Google Scholar
• Kwok SK, Seo SH, Ju JH, et al. Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody. Lupus. 2007;16(10):803–809. doi: 10.1177/0961203307082383.
   PubMed Web of Science ®Google Scholar
• Pippias M, Stel VS, Aresté-Fosalba N, et al. Long-term kidney transplant outcomes in primary glomerulonephritis: analysis from the ERA-EDTA registry. Transplantation. 2016;100(9):1955–1962. doi: 10.1097/TP.0000000000000962.
   PubMed Web of Science ®Google Scholar